Róbert Wessman, Alvotech CEO
Troubled Reykjavik plant lands Alvotech a second CRL for its potential Humira biosimilar
Billionaire Róbert Wessman’s Alvotech is continuing to run into manufacturing deficiencies at a Reykjavik plant, leading to a second complete response letter for its potential …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.